PharmTech Europe, Weekly Alert
Having trouble viewing this e-mail? CLICK HERE

PharmTech Europe
03 July 2018

PHARMTECH.COM

CURRENT ISSUE

SUBSCRIBE

FORWARD

twitter twitter
advertisement

Top Stories

GE Spins Off Healthcare Unit as Stand-alone Business

Strategic restructuring is designed to position GE Healthcare as a pure-play healthcare company.
/ read more /


US and EU Talk Inspections, Generics, and Advanced Therapies at Bilateral Meeting

FDA, EMA, and senior officials from the European Commission met to discuss the EU–US mutual recognition agreement for inspections, the development of advanced therapies, the requirements for approving generic drugs, and real-world evidence used for post-authorization monitoring.
/ read more /

advertisement

Subscribe

Subscribers can enjoy each full issue of Pharm Tech Europe in print, or via Pharm Tech Europe apps.

subscription offers
subscribe

Industry News

Ionic Pill Could Replace Daily Injections for Diabetics

A new oral delivery method developed by the Harvard John A. Paulson School of Engineering and Applied Sciences could change the way diabetics regulate blood sugar levels.
/ read more /


Data Integrity Issues Found at China Facility

FDA sent a warning letter to Henan Lihua Pharmaceutical Co. Ltd. after inspectors found the company failed to ensure the accuracy of its data.
/ read more /


More Industry News
advertisement

Regulatory News

FDA Approves Generic Suboxone Sublingual Film for Opioid Dependence Treatment

The approval is intended to increase patient access to treatment for opioid addiction.
/ read more /


FDA Approves First Cannabidiol-based Drug

GW Research's Epidiolex, which treats two forms of epilepsy, receives FDA's approval; spurs FDA reminders about unapproved products.
/ read more /


More Regulatory News

Bio/Pharma News

AbbVie and Calibr Partner on T-cell Therapies

The companies will partner to develop T-cell therapies for cancer.
/ read more /


Sanofi Pasteur, Translate Bio in $805-Million Deal to Develop mRNA-Based Vaccines

The three-year collaboration will focus on developing vaccines for up to five infectious disease pathogens.
/ read more /


More Bio/Pharma News

Supplier News

CellGenix Completes First Step of Facility Expansion for Cell-Culture Reagents

The company has completed the first phase of expansion at its headquarters in Freiburg, Germany, in anticipation of increasing demand as cell and gene therapies approach commercialization.
/ read more /


 

Minakem Opens New High Containment Facility

Minakem's facility in Belgium enhances capacity to scale production of highly potent ingredients for small to full GMP batches.
/ read more /


More Supplier News

FEATURED TOPICS

VACCINES

Modern Manufacturing Key to More Effective Vaccines

Accelerated development of new preventives raises challenges for efficient CMC evaluation and production.
/ read more /

 

VIEWPOINTS

Let the Learning Commence

By minding knowledge gaps, bio/pharma companies can avoid development pitfalls.
/ read more /

QUALITY SYSTEMS

Simple by Design

Research is focusing on ways to extend dissolution testing, improve in-vitro and in-vivo correlation, and make real-time release testing a reality.
/ read more /

DRUG DELIVERY

A Novel Amorphous Delivery System to the Skin for Poorly Soluble Actives

Drugs in the amorphous form are loaded into porous silica particles, which provide a maintained concentration gradient for skin delivery.
/ read more /


ON DEMAND WEBCAST

Continuous Processing in Biomanufacturing
On Demand
Learn more


Events

SMi's 13th Annual ADMET Conference

London, United Kingdom

9–10 July 2018

16th International Conference and Exhibition on Pharmaceutical Formulations

Rome, Italy

26–27 July 2018


more events

eBOOKS

Biologics and Sterile Drug Manufacturing 2018

This ebook covers novel technologies for the formulation, manufacture, purification, and delivery of sterile small- and large-molecule drugs, including single-use systems, facilities and equipment, contamination issues, and process analytics.

contribute | CONTACT EDITORS | CONTACT SALES | subscribe | advertise